APRE Financial Analysis, Income Statement and Balance Sheet
Aprea Therapeutics, Inc.
At Close: 4:00 PM
Pre Market: 4:28 AM
Frequently Asked Questions
How did Aprea Therapeutics, Inc. do last quarter? What was its Total Revenue and Cost of Revenue?
A company's Total Revenue reveals how much money it generates before any expenses or deductions are made. As a result, this metric informs investors/stakeholders how much money the business makes. Tracking and understanding it is essential for evaluating a company's growth. As opposed to revenue, Cost of Revenue is any expenses a business incur to generate revenue. There can be high revenue in a business, but if the costs are high, it won't make a profit and will go out of business when money runs out. Therefore, APRE generated $0 in revenue last quarter, while its costs came in at $0.
Last quarter, how much Gross Profit did Aprea Therapeutics, Inc. report?
A business's Gross Profit is a key indicator of its profitability and financial performance. In other words, it reflects how efficiently a business uses labor, raw materials, and other resources. Aprea Therapeutics, Inc. reported a $0 Gross Profit for the quarter ended Dec. 2021.
Have APRE's Total Operating Expenses and Operating Income been favorable recently?
Operational Expenses represent the costs a company must incur to generate revenue, which is the ultimate goal of a business, whereas Operating Income shows the revenue left after operational direct and indirect costs have been deducted. APRE incurred $7.83M worth of Operating Expenses, while it generated -$7.83M worth of Operating Income.
How much Net Income has APRE posted recently?
The Net Income of a company is one of the factors investors consider when investing in the company. According to recent earnings report from Aprea Therapeutics, Inc., the company generated -7.76M i Net Income. When a company has a history of consistent net income, investors are more likely to invest in it since they know they will get a return.
At the end of the last quarter, how much Cash and Equivalents did Aprea Therapeutics, Inc. have?
The amount of Cash and Cash Equivalents is an effective indicator of the financial strength and well-being of a company. An excess cash situation occurs when a company has more cash and cash equivalents than it needs for operating activities. The amount of Cash and Cash Equivalents available to Aprea Therapeutics, Inc. as of the end of the last quarter was $33.11M.
What are APRE's Total Net Receivables for the last quarter?
Total Net Receivables are a company's outstanding debts to its customers. Therefore, it refers to the amount that a company expects to collect from its customers. The higher a company's net receivables are, the more confident it is that it can collect money from its debtors. As of the end of the last quarter, APRE had Total Net Receivables of $0.
In terms of Total Assets and Current Assets, where did Aprea Therapeutics, Inc. stand at?
An asset with an economic value within a year is considered a current asset. Total assets, however, also include long-term fixed assets, intangible assets, and other non-current assets. The current Assets of APRE total $33.47M, while the Total Assets are $33.62M.
As of the last quarter, how much Total Debt did Aprea Therapeutics, Inc. have?
The total debt of a business refers to how much it borrows. A company's current and long-term liabilities are added together to calculate its Total Debt. A debt ratio may be taken into account on a balance sheet by financial lenders, investors, and business leaders when making informed decisions about future loans or investments. The total amount of APRE's debt was $110551 at the end of the last quarter.
What were APRE's Total Liabilities during the last reported quarter?
A company's total liabilities are the sum of all debts it is liable for, including any off-balance shee liabilities it may incur. This can be calculated by adding up all short-term and long-term liabilities. In its last quarter, APRE reported total liabilities of $7.00M.
How much did APRE's Working Capital change over the last quarter?
Working Capital Change for APRE was -$2.64M over the last quarter. Working Capital Change refers to the difference between net working capital amounts at the end of one accounting period and the end of another. It tells investors/stakeholders how much the company's cash flow will differ from its Net Income (i.e., after-tax profits). More powerful companies often have positive Change in Working Capital numbers as they have increased control over collecting cash from customers and delaying payments to suppliers.
APRE generated how much cash from operating activities?
An operating cash flow statement usually contains cash from operating activities in the first section. An organization's cash from operating activities refers to the money it takes in and takes out as a result of its regular business operations. APRE generated -$6.59M of Cash from Operating Activities during its recently reported quarter.
What was APRE's latest reported Net Change in Cash?
An increase or decrease in cash and cash equivalent balances within a specified period is considered the net change in cash in a cash flow statement. Furthermore, it takes into account cash changes as a result of investments, financing, and operating activities. APRE reported a -$5.95M Net Change in Cash in the most recent quarter.